What's New

Medical News
& Alerts

Conferences
& Meetings


Other Medical
Resources

Employment
Opportunities

Partnering
Opportunities

Search results for: Clopidogrel
96%DGNews: FDA: Avoid Coadministration of Clopidogrel and Omeprazole, Esomeprazole
96%DGNews: EMEA Recommends Clopidogrel Label Change to Include Possible PPI Interaction
96%DGNews: Clopidogrel Plus PPI Increase Risk of Death, Hospitalisation in Patients With ACS
96%DGNews: Clopidogrel Not Contraindicated Before Kidney Transplantation, Study Results Suggest: Presented at ATC
95%DGNews: Antithrombotics Increase Risk of Hospital Admission for Bleeding in MI Patients
95%DGNews: Ticagrelor Superior to Clopidogrel in Reducing Vascular Events, Death in Patients With Acute Coronary Syndrome: Presented at ESC(CARD)
95%DGNews: Genetic Variation Associated With Poorer Response to Clopidogrel Following PCI
95%DGNews: Effectiveness of Clopidogrel May Be Reduced by Common Heartburn Drugs: Presented at SCAI
95%DGNews: ACC/AHA Comments on Possible Interaction of Clopidogrel, PPIs
95%DGNews: Patients at Risk of Adverse Events Within 3 Months After Stopping Certain ACS Therapy
95%DGNews: Severe Bleeding Rate With Clopidogrel/Aspirin Comparable to That of Warfarin: Presented at AHA
95%DGNews: Clopidogrel Reduces Recurrent Vascular Events With Better Safety Profile Than Ticlopidine in Japanese Stroke Patients: Presented at ESC
95%DGNews: Efficacy of Clopidogrel in Patients Undergoing Coronary Stenting Depends on Loading Dose: Presented at SCAI
95%DGNews: Clopidogrel Helps Reduce Mortality in Patients With Diabetes After Stent Implantation: Presented at SCAI
95%DGNews: Extended Use of Clopidogrel in Patients with Drug-Eluting Stents Associated with Lower Risk of Death or Heart Attack
95%DGNews: Study Shows Prasugrel Achieves Faster Onset and Higher Levels of Platelet Inhibition than Clopidogrel at Approved or Higher Doses
95%DGNews: Clopidogrel as Adjunctive Reperfusion Therapy for Thrombosis in Myocardial Infarction: Presented at ESC
95%DGNews: Clopidogrel Appears to Reduce Risk of Heart Attack, Stroke and Cardiovascular Death Before and After Angioplasty
95%DGNews: ACC: Platelet Inhibition More Consistent With Prasugrel Than Clopidogrel
95%DGNews: ACC: Adding Clopidogrel to Aspirin Therapy Reduces Risk of Death and Complications After Major Heart Attacks
95%DGNews: Integrilin (Eptifibatide) Injection Plus Clopidogrel Appears to Provide Superior Platelet Inhibition and Reduced Heart Muscle Death
95%DGNews: DG DISPATCH - ACC: Plavix (Clopidogrel) Superior To Aspirin For Preventing Acute Coronary Events
95%DGNews: DG DISPATCH - TCT: Clopidogrel Safer Than Ticlopidine In Thrombosis Prevention
95%DGNews: Clopidogrel Demonstrates Superior Benefit in Patients at Risk of Stroke
94%DGNews: High-Dose Clopidogrel Reduces Vascular Events in Patients Undergoing PCI: Presented at ESC
94%DGNews: PPIs Thwart Clopidogrel's Anticlotting Effectiveness in Diabetics Post Stenting: Presented at ADA
94%DGNews: Clopidogrel Plus Aspirin Improves Outcomes in Patients With Atrial Fibrillation Not Taking Warfarin: Presented at ACC
94%DGNews: Tailored Clopidogrel Treatment Reduces Risk of Stent Thrombosis: Presented at AHA
94%DGNews: Canadian Cardiovascular Outcomes Improve With Faster Access to Clopidogrel: Presented at CCC
94%DGNews: Extended-Release Dipyridamole Plus Aspirin Fails to Prove Non-Equivalence With Clopidogrel: Presented at ESC
94%DGNews: Clopidogrel May Not Increase Suitability for Haemodialysis of Surgically Enlarged Fistulas
94%DGNews: Abciximab Fails to Add Benefit in Acute Myocardial Infarction for Patients Preloaded With Clopidogrel Undergoing Percutaneous Interventions: Presented at SCAI
94%DGNews: Investigative Prasugrel Reduces Cardiac Events Versus Clopidogrel: Presented at AHA
94%DGNews: Longer Use of Anti-Clotting Treatment with Drug-eluting Stents May Reduce Risk of Death
94%DGNews: Desensitization Can Eliminate Clopidogrel Allergy: Presented at SCAI
94%DGNews: AZD6140 Shows Promise in Acute Coronary Syndrome: Presented at AHA
94%DGNews: ACC: Plavix (Clopidogrel) Helps Retain Patency of Reperfused Coronary Arteries
94%DGNews: ACC: Prasugrel Shows Better Platelet Inhibition Than Clopidogrel
94%DGNews: Some Heart Attack Patients May Be Resistant to Clopidogrel
94%DGNews: ISC: ASA-Clopidogrel Combination Enhances Antiplatelet Response in Cerebrovascular Disease
94%DGNews: AHA: Year-Long Clopidogrel Therapy Reduces Coronary Events in Angioplasty-eligible Patients
94%DGNews: CCC: Clopidogrel and ASA Proposed New Treatment Module for Unstable Angina
94%DGNews: FDA Grants Priority Review to Supplemental New Drug Application for Plavix (Clopidogrel)
94%DGNews: ESC: Heart Attack And Death Reduced Following Angioplasty With Clopidogrel
94%DGNews: Clopidogrel Receives European Marketing Approval For Atherosclerotic Events
93%DGNews: Ticagrelor Superior to Clopidogrel for Management of Patients With ACS Undergoing PCI
93%DGNews: No Significant Benefits to Adding Clopidogrel to Aspirin After Coronary Bypass Surgery: Presented at AHA
93%DGNews: Aspirin Plus Clopidogrel After TIA or Minor Stroke Confers Significant Bleeding Risk in Aspirin-Naïve Patients: Presented at ESC
93%DGNews: Certain PPIs Increase Risk of Heart Attacks for Patients on Clopidogrel
93%DGNews: Can Aspirin With Clopidogrel or Statins Reduce Recurrent Stroke Risk? Presented at ESC
Enter keywords you wish to find information about:

Search for documents that contain:
any of these words.
this exact phrase.
all of these words.

 

 

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.

All contents Copyright (c) 1998 PSL Consulting Group Inc.
all rights reserved.